Literature DB >> 13545522

Antituberculosis activity in the phenazine series. II. N3-substituted anilinoaposafranines (rimino-compounds) and some derivatives.

V C BARRY, M L CONALTY.   

Abstract

Entities:  

Keywords:  DYES/effects; HETEROCYCLIC COMPOUNDS/effects; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1958        PMID： 13545522     DOI： 10.1164/artpd.1958.78.1.62

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  12 in total

1.  Drug treatment of experimental silicosis.

Authors:  D M JAMES; T G MORRIS; J MARKS
Journal:  Br J Ind Med       Date:  1960-01

2.  Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

Authors:  B M Zeis; R Anderson; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 3.  [Mycobacterium ulcerans infection in man (Baruli-ulcer)].

Authors:  G Kieninger; G E Schubert; U Ullmann; W Höfler
Journal:  Infection       Date:  1973       Impact factor: 3.553

4.  Experimental chemotherapy of tuberculosis.

Authors:  J Batten
Journal:  Br Med J       Date:  1968-07-13

Review 5.  Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

Authors:  M Gopal; N Padayatchi; J Z Metcalfe; M R O'Donnell
Journal:  Int J Tuberc Lung Dis       Date:  2013-03-25       Impact factor: 2.373

6.  Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.

Authors:  S G Franzblau; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

7.  Evidence for the presence of clofazimine and its distribution in the healthy mouse brain.

Authors:  Sooraj Baijnath; Suhashni Naiker; Adeola Shobo; Chivonne Moodley; John Adamson; Bongani Ngcobo; Linda A Bester; Sanil Singh; Hendrik G Kruger; Tricia Naicker; Thavendran Govender
Journal:  J Mol Histol       Date:  2015-07-25       Impact factor: 2.611

Review 8.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

9.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Authors:  C E Van Rensburg; G K Jooné; J F O'Sullivan; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 10.  Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review.

Authors:  Klaudia T Angula; Lesetja J Legoabe; Richard M Beteck
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.